CASE REPORT. Membranoproliferative associated with type II in a renal transplant patient with hepatitis C. Glomerulonefrite membranoproliferativa em. Disease definition. Dense deposit disease, a histological subtype of MPGN (see this term) is an idiopathic chronic progressive kidney disorder distinguished by. Glomerulonefrite membranoproliferativa. Classificação Até achados estruturais e histopatológico fisiopatologia e.

Author: Tozilkree Grojind
Country: Central African Republic
Language: English (Spanish)
Genre: Love
Published (Last): 10 January 2005
Pages: 129
PDF File Size: 3.75 Mb
ePub File Size: 19.47 Mb
ISBN: 874-5-40829-380-7
Downloads: 87119
Price: Free* [*Free Regsitration Required]
Uploader: JoJoshakar

Other glomerular diseases have also been reported, such as membranous nephropathy, minimal change disease, thrombotic microangiopathy, acute transplant glomerulopathy and chronic transplant glomerulopathies 1,4,5.

Post-transplantation morbidity in renal transplant patients with hepatitis C virus HCV infection may be partially explained by the risk of de novo or recurrent HCV associated glomerulopathieswhich can lead to allograft dysfunction. J Nephropathol ;2 4: For these reasons we decided to treat the patient with this drug. The patient was lost for follow-up. The association between race and histologic type was not influenced by the potential effects of age, gender and hepatosplenic schistosomiasis.

Glomerulonefrite membranoproliferativa

The patient membrano;roliferativa not receive any previous antiviral therapy. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.


Patients with systemic lupus erythematosus or any kind of autoimmune disease were not included in the present analysis. Renal function progressively worsened to a maximum of SCr of 2. Os anticorpos antinuclear e anti-double stranded DNA foram negativos.

Clin J Am Soc Nephrol ;2 3: An allograft biopsy was performed and showed lesions compatible with MPGN. Autoimmun Rev ;10 To date, there are no studies of this therapy in renal transplant and randomized controlled trials are needed The data support the possibility of a greater susceptibility to FSG among negroes and mulattoes, independently of age, gender and schistosomiasis.

Foi perdido o follow-up do doente. We report a case of membranoproliferative glomerulonephritis associated with type II in a year-old Caucasian membrannoproliferativa recipient of a deceased kidney transplant in Check this box if you wish to receive a copy of your message.

Como citar este artigo. In our case, the treatment with rituximab resulted in a favourable outcome, although a longer follow-up period may be needed to evaluate the clinical response, since other studies reported high relapse rates.

Glomerulonefrite membranoproliferativa by Isabela Alcântara on Prezi

The most common HCV-related nephropathy is membranoproliferative glomerulonephritis MPGNusually in the context of cryoglobulinaemia 6,7. Kidney Int ;69 3: Hepatitis C virus, glomerulonefritf, and kidney: Management of the kidney transplant patient with chronic hepatitis C infection.


To assess the association between race and type of glomerulonephritis, taking into account age, gender and the presence of hepatosplenic schistosomiasis mansoni.

Hepatitis C virus infection as a risk factor for graft loss after renal membranoprolifreativa In: This form often has a higher recurrence rate after a kidney transplant and is associated with extra-renal manifestations such as familial drusen see this term. According to KDIGO clinical practice guidelines oftreatment with interferon should be reserved to patients with fibrosing cholestatic hepatitis or life-threatening vasculitis KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

Hepatitis C virus infection in nephrology patients.

Orphanet: Glomerulonefrite membranoproliferativa tipo 2

He had a history of illicit drug abuse cocaine and heroin with membranoprpliferativa replacement therapy since The management is critical and the main purpose is to improve long-term allograft survival. The treatment of this entity is not consensual and represents a challenge to clinicians.

Race; Black; Glomerulonefritis; Schistosomiasis. Iran J Kidney Dis ;4 1: Rituximab induces regression of hepatitis C virus-related membranoproliferative in a renal allograft.

Author: admin